Search research articles
Contact Us
Filters
Showing results (351-360 of 418) with videos related to
Page
of 42
Sort By:
Schizophrenia Research
|
March 16, 2013
Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls
Anthony J Rissling, Sung-Hyouk Park, Jared W Young, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 1, 2018
Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia
William C Hochberger, Yash B Joshi, Michael L Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 19, 2022
EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participants
Savita G Bhakta, James F Cavanagh, Jo A Talledo, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
September 8, 2023
Effects of Memantine on the Auditory Steady-State and Harmonic Responses to 40 Hz Stimulation Across Species
Neal R Swerdlow, Christopher E Gonzalez, Muhammad Ummear Raza, et al.
Kidney International
|
May 1, 1979
Restrospective correlation of clinical and histologic findings of 189 exchanged kidneys
N Ende, J C Pierce, F Westervelt, et al.
Psychiatry Research
|
July 5, 2023
Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disorders
Yash B Joshi, Christopher E Gonzalez, Juan L Molina, et al.
Journal of Alzheimer'S Disease : JAD
|
October 25, 2021
Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration
Neal R Swerdlow, Juliana E Kotz, Yash B Joshi, et al.
Psychiatry Research
|
October 4, 2025
Do cognitive and neurophysiological effects of acute memantine "challenge" predict its clinical benefits in Alzheimer's Disease?
Neal R Swerdlow, Joyce Sprock, Christopher E Gonzalez, et al.
Cognitive, Affective & Behavioral Neuroscience
|
January 3, 2024
Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarker
Michael Noback, Savita G Bhakta, Jo A Talledo, et al.
Schizophrenia Research
|
January 21, 2019
Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia
Emily B H Treichler, Michael L Thomas, Andrew W Bismark, et al.
Page
of 42
Search research articles
Search
Showing results (351-360 of 418) with videos related to
Sort By:
Page
of 42
Schizophrenia Research
|
March 16, 2013
Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls
Anthony J Rissling, Sung-Hyouk Park, Jared W Young, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 1, 2018
Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia
William C Hochberger, Yash B Joshi, Michael L Thomas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 19, 2022
EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participants
Savita G Bhakta, James F Cavanagh, Jo A Talledo, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
September 8, 2023
Effects of Memantine on the Auditory Steady-State and Harmonic Responses to 40 Hz Stimulation Across Species
Neal R Swerdlow, Christopher E Gonzalez, Muhammad Ummear Raza, et al.
Kidney International
|
May 1, 1979
Restrospective correlation of clinical and histologic findings of 189 exchanged kidneys
N Ende, J C Pierce, F Westervelt, et al.
Psychiatry Research
|
July 5, 2023
Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disorders
Yash B Joshi, Christopher E Gonzalez, Juan L Molina, et al.
Journal of Alzheimer'S Disease : JAD
|
October 25, 2021
Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration
Neal R Swerdlow, Juliana E Kotz, Yash B Joshi, et al.
Psychiatry Research
|
October 4, 2025
Do cognitive and neurophysiological effects of acute memantine "challenge" predict its clinical benefits in Alzheimer's Disease?
Neal R Swerdlow, Joyce Sprock, Christopher E Gonzalez, et al.
Cognitive, Affective & Behavioral Neuroscience
|
January 3, 2024
Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarker
Michael Noback, Savita G Bhakta, Jo A Talledo, et al.
Schizophrenia Research
|
January 21, 2019
Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia
Emily B H Treichler, Michael L Thomas, Andrew W Bismark, et al.
Page
of 42